Form 4: iBio Director Brenner Acquires Shares in Recent Transaction
SEC Form 4
Director and Officer Martin Brenner reports acquisition of iBio, Inc. shares via a Securities Purchase Agreement.
Summary
- On January 10, 2025, Martin Brenner, a Director and Officer (Chief Executive Officer and Chief Scientific Officer) of iBio, Inc., acquired 9,191 shares of common stock at a price of $2.72 per share.
- This transaction was made pursuant to a Securities Purchase Agreement with iBio, Inc.
- Following the reported transaction, Brenner directly owns 18,316 shares of iBio, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The purchase could be seen as a positive signal, but without further context, it's difficult to assess the overall impact.
Industry Context
This filing reflects insider trading activity, which is closely monitored by regulators and investors for insights into management's perspective on the company's prospects.
Related Party Transactions
- The share purchase was made pursuant to a Securities Purchase Agreement with iBio, Inc., indicating a transaction between the reporting person and the company.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder confidence as it signals insider investment in the company.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Date of transaction: Martin Brenner purchased shares of iBio, Inc. |
| 01/13/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.